Synonym: expanded access.

Providing seriously ill patients with access outside of clinical trials to a new, unapproved drug when other treatment options have been exhausted or none is yet available.

Regulatory authorities provide guidance outlining the circumstances when compassionate use can be considered and the procedures that should be followed.